Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco, Milan, Italy.
Department of Biomedical and Clinical Sciences, Romeo ed Enrica Invernizzi Paediatric Research Centre, University of Milan, Milan, Italy.
Infection. 2024 Aug;52(4):1633-1638. doi: 10.1007/s15010-024-02232-x. Epub 2024 Apr 1.
Candida auris, an emerging multidrug-resistant yeast, has been reported worldwide. In Italy, the first case was reported in 2019. We describe the first case of C. auris, imported from Greece, in Milan, using whole genome sequencing to characterise mutations associated with antifungal resistance.
On October 2022 an 80-year-old Italian man was hospitalised in Greece. In the absence of clinical improvement, the patient was transferred to our hospital, in Italy, where blood culture resulted positive for C. auris. Despite therapy, the patient died of septic shock. In a phylogenetic analysis the genome was assigned to Clade I with strains from Kenya, United Arab Emirates and India. D1/D2 region resulted identical to a Greek strain, as for many other strains from different World regions, highlighting the diffusion of this strain.
Importation of C. auris from abroad has been previously described. We report the first case of C. auris imported into Italy from Greece, according to phylogenetic analysis. This case reinforces the need for monitoring critically ill hospitalised patients also for fungi and addresses the need for the standardisation of susceptibility testing and strategies for diagnosis and therapy.
耳念珠菌是一种新兴的多药耐药酵母,已在全球范围内报道。在意大利,首例病例于 2019 年报告。我们通过全基因组测序描述了首例从希腊进口到米兰的耳念珠菌病例,以确定与抗真菌耐药性相关的突变。
2022 年 10 月,一名 80 岁的意大利男性在希腊住院。由于临床症状没有改善,患者被转至我们所在的意大利医院,血液培养结果显示为耳念珠菌阳性。尽管进行了治疗,患者仍死于败血症性休克。在系统发育分析中,该基因组被分配到肯尼亚、阿拉伯联合酋长国和印度的菌株所在的 I 型分支。D1/D2 区与来自希腊的菌株完全相同,与来自不同世界区域的许多其他菌株一样,这突出了该菌株的传播。
从国外进口耳念珠菌已有先前报道。我们报告了首例从希腊进口到意大利的耳念珠菌病例,根据系统发育分析。该病例再次强调了需要对重症住院患者进行真菌监测,并需要标准化药敏试验以及诊断和治疗策略。